Publication | Closed Access

Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum

Ercc1 OverexpressionMedicinePathologyCancer TreatmentCancer GeneticsOncologyRadiation OncologyBrca1 UnderexpressionLung Cancer